Detalhe da pesquisa
1.
A phase I study of the VEGFR kinase inhibitor vatalanib in combination with the mTOR inhibitor, everolimus, in patients with advanced solid tumors.
Invest New Drugs
; 38(6): 1755-1762, 2020 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-32328844
2.
Phase I trial of sorafenib in combination with gefitinib in patients with refractory or recurrent non-small cell lung cancer.
Clin Cancer Res
; 13(9): 2684-91, 2007 May 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-17473200
3.
A phase I and pharmacologic study of sequences of the proteasome inhibitor, bortezomib (PS-341, Velcade), in combination with paclitaxel and carboplatin in patients with advanced malignancies.
Cancer Chemother Pharmacol
; 59(2): 207-15, 2007 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-16763792
4.
A phase I trial of the novel farnesyl protein transferase inhibitor, BMS-214662, in combination with paclitaxel and carboplatin in patients with advanced cancer.
Clin Cancer Res
; 11(5): 1877-83, 2005 Mar 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-15756013
5.
A phase I and pharmacologic trial of two schedules of the proteasome inhibitor, PS-341 (bortezomib, velcade), in patients with advanced cancer.
Clin Cancer Res
; 11(9): 3410-6, 2005 May 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-15867242
6.
Complementary and alternative medicine use by patients enrolled onto phase I clinical trials.
J Clin Oncol
; 22(23): 4810-5, 2004 Dec 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-15570083
7.
Phase II study of the farnesyl transferase inhibitor R115777 in patients with advanced non-small-cell lung cancer.
J Clin Oncol
; 21(9): 1760-6, 2003 May 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-12721252
8.
Comparative pharmacokinetic study of continuous venous infusion fluorouracil and oral fluorouracil with eniluracil in patients with advanced solid tumors.
J Clin Oncol
; 20(6): 1683-91, 2002 Mar 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-11896120
9.
A phase I trial of celecoxib in combination with docetaxel and irinotecan in patients with advanced cancer.
Cancer Chemother Pharmacol
; 56(6): 623-8, 2005 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-15999272
10.
A phase IB study of the pharmacokinetics of gemcitabine and pemetrexed, when administered in rapid sequence to patients with advanced solid tumors.
Cancer Chemother Pharmacol
; 55(6): 522-30, 2005 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-15754203
11.
A Phase I trial of the farnesyl protein transferase inhibitor R115777 in combination with gemcitabine and cisplatin in patients with advanced cancer.
Clin Cancer Res
; 9(7): 2520-6, 2003 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-12855626
12.
A phase I trial of ISIS 2503, an antisense inhibitor of H-ras, in combination with gemcitabine in patients with advanced cancer.
Clin Cancer Res
; 9(1): 115-23, 2003 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-12538459
13.
Phase I pharmacokinetic and pharmacodynamic study of the oral, small-molecule mitogen-activated protein kinase kinase 1/2 inhibitor AZD6244 (ARRY-142886) in patients with advanced cancers.
J Clin Oncol
; 26(13): 2139-46, 2008 May 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-18390968
14.
A phase I and pharmacologic study of pyrazoloacridine (NSC 366140) and carboplatin in patients with advanced cancer.
Invest New Drugs
; 20(3): 297-304, 2002 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-12201492